Several sources are reporting Merck and a partner named Ridgeback Biotherapeutics have developed an anti-viral pill - Molnupiravir - that dramatically improves the survival chances of Covid-19 patients. John Hinderaker at Power Line has a nice write-up which notes the London Times reports:
On seeing the results the US Food and Drug Administration recommended stopping the trial and applying for an emergency use authorisation for the drug immediately.
This could be very big, very important. As Instapundit is fond of writing: Faster, please.
